type here...

CATEGORIES

Pharmaceutics

LATEST

1...789...11Page 8 of 11

TRENDING

EDITORS CHOICE

Three Ways I Drop Stress in the Omicron Era – A Doctor’s Approach

Michael Hunter, MD -
THE LAST CHAPTER OF THE COVID-19 pandemic era, many of us hoped. Now, as many of you are, I am uncertain. Stress abounds, and in...

Is Silmitasertib the Covid-19 Treatment Breakthrough We’ve Been Waiting for?

Medika Life -
Within 24 hours of the first dose of Silmitasertib the patient showed significant clinical improvement and the oxygen requirement was weaned to room air. The patient was discharged from the hospital five days after starting Silmitasertib.

FDA approves Ready-to-Use Ephedrine Injection, Emerphed™

Medika Life -
Nexus Pharmaceuticals, Inc. Announces Approval of Emerphed™ (ephedrine sulfate) Injection, the First and Only FDA-approved, Ready-to-Use Ephedrine Injection (50 mg/10 mL vial)

Baby Born With Protective Antibodies After Maternal Covid-19 Vaccination

Dr Jeff Livingston -
No pregnant person's birth plan was to deliver their baby during a global pandemic. The more than 3.7 million individuals who give birth in the United...

CONNECT WITH US ON SOCIAL MEDIA

Medika Life is a unique, not-for-profit operating unit of FINN Partners and maintains an independent voice. Authors opinions may not necessarily represent those shared by FINN Partners and content cannot be promotional - rather informational centered on health issues, life science innovation, ecohealth and patient experience.

© Medika Life 2020 - 2022

Compliance

CORPORATE & MEDIA

Popular categories